Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-25-022455

SVP, Head of Finance & Admin. sold 2,488 shares at $13.95 ($34,708)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Scalzo Richard William SVP, Head of Finance & Admin. 2025-02-18 Sale 10b5-1 −2,488 $13.95 $34,708 124,590 D: show line 1 in the form
Open-market sales · 2,488 sh · avg $13.95 · $34,708
Loading xslF345X05/ownership.xml…